214 related articles for article (PubMed ID: 15278190)
1. Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
Chen CY; Lirng JF; Chan WP; Fang CL
J Formos Med Assoc; 2004 Jun; 103(6):448-58. PubMed ID: 15278190
[TBL] [Abstract][Full Text] [Related]
2. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
3. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
[TBL] [Abstract][Full Text] [Related]
4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
6. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
7. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.
Shimizu H; Kumabe T; Shirane R; Yoshimoto T
AJNR Am J Neuroradiol; 2000 Apr; 21(4):659-65. PubMed ID: 10782774
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
[TBL] [Abstract][Full Text] [Related]
9. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
[TBL] [Abstract][Full Text] [Related]
10. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
11. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.
McKnight TR; Lamborn KR; Love TD; Berger MS; Chang S; Dillon WP; Bollen A; Nelson SJ
J Neurosurg; 2007 Apr; 106(4):660-6. PubMed ID: 17432719
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
13. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.
Su C; Liu C; Zhao L; Jiang J; Zhang J; Li S; Zhu W; Wang J
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1702-1709. PubMed ID: 28729292
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
[TBL] [Abstract][Full Text] [Related]
15. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of cerebral glioma after irradiation.
Ng SH; Ko SF; Chen WC; Tang LM; Chang CN; Wai YY; Wan YL
Chang Gung Med J; 2001 Nov; 24(11):708-16. PubMed ID: 11820651
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
Negendank WG; Sauter R; Brown TR; Evelhoch JL; Falini A; Gotsis ED; Heerschap A; Kamada K; Lee BC; Mengeot MM; Moser E; Padavic-Shaller KA; Sanders JA; Spraggins TA; Stillman AE; Terwey B; Vogl TJ; Wicklow K; Zimmerman RA
J Neurosurg; 1996 Mar; 84(3):449-58. PubMed ID: 8609557
[TBL] [Abstract][Full Text] [Related]
20. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]